REGENERON PHARMACEUTICALS (RGO.DE) Stock Analyst Ratings

FRA:RGO • US75886F1075

675.6 EUR
+12.4 (+1.87%)
Last: Feb 13, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Buy % Consensus

81

ChartMill assigns a Buy % Consensus number of 81% to RGO.DE. The Buy consensus is the weighted average rating of the current analysts ratings.

  • Analysts have set a mean price target forecast of 730.57. This target is 8.14% above the current price.
  • RGO.DE was analyzed by 36 analysts. The buy percentage consensus is at 81. So analysts seem to be very confident about RGO.DE.
  • In the previous month the buy percentage consensus was at a similar level.
  • RGO.DE was analyzed by 36 analysts, which is quite many. So the average rating should be quite meaningful.

Related screens

Find peers with buy consensus above 85%
RGO.DE Historical Analyst RatingsRGO.DE Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 10 20 30

Price Target & Forecast

Price Low Median Mean High 675.60564.70747.42730.57940.19 - -16.42% 10.63% 8.14% 39.16%

Related screens

Find peers 30% below price target
RGO.DE Current Analyst RatingRGO.DE Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 5 10 15
Up and Down Grades
Date Firm Action Rating
2021-08-06 Oppenheimer Maintains Outperform
2021-08-06 SVB Leerink Maintains Outperform
2021-08-06 Barclays Maintains Overweight
2021-08-02 HC Wainwright & Co. Maintains Buy
2021-07-08 Benchmark Maintains Buy
2021-06-29 HC Wainwright & Co. Initiate Buy
2021-05-07 SVB Leerink Maintains Outperform
2021-05-07 Morgan Stanley Maintains Equal-Weight
2021-04-19 Morgan Stanley Maintains Equal-Weight
2021-03-26 SVB Leerink Maintains Outperform
2021-02-23 Credit Suisse Maintains Outperform
2021-02-16 Cantor Fitzgerald Maintains Overweight
2021-02-08 SVB Leerink Maintains Outperform
2021-02-08 Cowen & Co. Maintains Outperform
2021-02-08 Credit Suisse Maintains Outperform
2021-02-08 Morgan Stanley Maintains Equal-Weight

REGENERON PHARMACEUTICALS / RGO.DE FAQ

What do analysts expect the price target to be for REGENERON PHARMACEUTICALS (RGO.DE)?

36 analysts have analysed RGO.DE and the average price target is 730.57 EUR. This implies a price increase of 8.14% is expected in the next year compared to the current price of 675.6.


How do analysts rate REGENERON PHARMACEUTICALS (RGO.DE)?

The consensus rating for REGENERON PHARMACEUTICALS (RGO.DE) is 81.1111 / 100 . This indicates that analysts generally have a positive outlook on the stock.


How many analysts have analysed REGENERON PHARMACEUTICALS (RGO.DE)?

The number of analysts covering REGENERON PHARMACEUTICALS (RGO.DE) is 36.